HURATuHURA Biosciences, Inc./NVvs its industry peers
A metric-by-metric comparison of TuHURA Biosciences, Inc./NV against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HURAThis | $137M#4 | — | 5.9x#5 | — | — | -34.8%#2 | — | -133.7%#5 | -0.1%#1 | — | — | — |
| AARD | $156M#1 | — | 1.8x#3 | — | — | -179.7%#4 | — | -66.2%#2 | — | — | — | — |
| KRRO | $155M#2 | — | 1.3x#2 | 24.3x#1 | 181.5%#1 | -40.3%#3 | -1906.4%#1 | -98.0%#4 | -209.7%#2 | — | — | — |
| UNCY | $135M#5 | — | 3.6x#4 | 199.8x#2 | -29.0%#2 | 27.7%#1 | -4372.9%#2 | -70.4%#3 | — | — | 20.9%#2 | — |
| CNTN | $140M#3 | — | 0.3x#1 | — | — | -194.5%#5 | — | -7.6%#1 | — | — | 63.9%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice